APOE and atherosclerosis: To determine whether TXNDC5 causatively drives atherosclerosis in vivo, we then engineered a new mouse line [Txndc5−/−::ApoE−/− (DKO)] in which Txndc5 is globally deleted in the background of ApoE−/− mice.